Stock Upgrades And Downgrades
Canaccord maintains its buy rating on Hologic (NASDAQ: HOLX) after it announced a buyout of Gen-Probe for $3.7. Canaccord also reiterated its buy rating on Watson Pharmaceuticals (WPI: NYSE) Goldman Sachs upgraded Community Health Systems (NYSE: CYH) to neutral. Bank of America Upgraded AstraZeneca (NYSE:…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Canaccord also reiterated its buy rating on Watson Pharmaceuticals (WPI: NYSE)
Goldman Sachs upgraded Community Health Systems (NYSE: CYH) to neutral.
Bank of America Upgraded AstraZeneca (NYSE: AZN) to neutral
Deutsche Bank downgraded Costco Wholesale (NASDAQ: COST) to hold
Pfizer Inc. (NYSE: PFE) reported first-quarter net income fell 19% on 6.6% lower revenue. Earnings were $1.79 billion, or 24 cents a share, compared with $2.22 billion, or 28 cents, in the year-earlier quarter. Adjusted earnings were 58 cents a share compared with 60 cents.
Thomson Reuters (NYSE: TRI) reported its first-quarter profit was $314 million, or 38 cents a share compared to $250 million, or 30 cents a share a year ago. Revenue rose to $3.654 billion, from $3.3 billion a year ago.
Avon Products Inc. (NYSE: AVP) reported an 82% drop in first-quarter profit to $26.5 million– 6 cents a share, from $143.6 million, or 33 cents, a share in the same quarter last year. Sales fell 2% to $2.53 billion for the quarter, down from $2.59 billion in the year-ago period.
Contact [email protected] for any questions or corrections.

